Gastrointestinal Disorders Pipeline Database - 2021

Gastrointestinal Disorders Pipeline Highlights Database - 2021, provides the most up-to-date information on key pipeline products in the global Gastrointestinal Disorders Drug market. It covers emerging therapies for Gastrointestinal Disorders in active clinical development stages including early and late-stage clinical trials. Key indications covered in this database include Gastro-esophageal reflux disease (GERD), Gastric ulcer, Peptic ulcer, Crohn's disease, Ulcerative colitis, and Irritable bowel syndrome. The pipeline data is presented in an excel dashboard with filtering options.

The pipeline data presented in this database helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

By Indication:

The database presents pipeline by Gastrointestinal Disorders indications. Key indications covered in this database include Gastro-esophageal reflux disease (GERD), Gastric ulcer, Peptic ulcer, Crohn's disease, Ulcerative colitis, and Irritable bowel syndrome.

By Clinical Trial Stages:

The database provides Gastrointestinal Disorders pipeline products by clinical trial stages including both early and late-stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

By Drug Mechanism Classes:

The database provides Gastrointestinal Disorders pipeline products by their dominant drug mechanism class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

By Company:

The database provides Gastrointestinal Disorders pipeline products by the company.

SUMMARY:

• Gastrointestinal Disorders Pipeline by Indication
• Gastrointestinal Disorders Pipeline by Clinical Trial Phase
• Gastrointestinal Disorders Pipeline by Drug Mechanism Classes
• Gastrointestinal Disorders Pipeline by Company